The MUSC Hematology & Oncology Fellowship Program began in 1986 and is the only hematology/oncology training program in the state of South Carolina. The program currently accepts four trainees into each class for the three-year combined hematology/oncology training. This program provides extensive clinical training in outpatient, inpatient, and consultative medical oncology and benign and malignant hematology, including autologous and allogeneic stem cell transplantation. Training in the basic principles and practice of hematology/oncology is provided to all fellows and additional training in basic and/or clinical research is available.
The Hematology & Oncology Fellowship is fully integrated with the clinical and translational research programs at MUSC's Hollings Cancer Center, allowing the opportunity for laboratory experiences, collaborative engagement, and participation in translational medicine. Fellows are expected to participate in the clinical and laboratory research activities and opportunities provided by the Cancer Center. The Hollings Cancer Center is a National Cancer Institute (NCI)-designated cancer center.
Deadline: Aug. 15, 2022
The program only accepts July 1 matriculates. The applications for matriculation are accepted only through the AAMC's ERAS system, and all applications for matriculation should be completed no later than August 15 in the year prior in order to be considered. Interview dates are typically in the fall. Applicants must be considered actively board-certified or board-eligible in internal medicine by the American Board of Internal Medicine or presently be in an internal medicine training program leading to such certification. Candidates who have passed the USMLE Step 3 exam are preferred, as passage of Step 3 is an institutional requirement for fellowship matriculation.
